IDEXX Laboratories Inc. closed 27.51% short of its 52-week high of $583.39, which the company reached on March 1st.

Shares of IDEXX Laboratories Inc. IDXX shed 0.94% to $418.63 Tuesday, on what proved to be an all-around positive trading ...

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2024 fourth quarter and full year financial results for Monday, February 3, 2025 ...

Signal Advisors Wealth LLC raised its stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) by 25.7% in the fourth ...

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2024 fourth quarter and full year financial results for Monday, February 3 ...

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2024 fourth quarter and full year financial results for Monday, February 3, 2025 ...

Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at ...

Browse 326 market data Tables and 55 Figures spread through 392 Pages and in-depth TOC on "Veterinary Infectious Disease Diagnostics Market by Technology (Immunodiagnostics, Molecular Diagnostics (PCR ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

It's that time again! "Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed. Louisiana-Pacific: "It's been a horse.

BTIG analyst Mark Massaro maintained a Buy rating on Castle Biosciences (CSTL – Research Report) today and set a price target of $40.00. The ...